Back to Markets

ABBV vs AMGN

A side-by-side look at ABBV and AMGN, updated throughout the trading session.

Performance, normalized

Z-scored closes: both paths on one scale, price levels aside.

Loading history…
Live figures are refreshing. Check back in a moment.

ABBV vs AMGN: how they differ

AbbVie Inc. (ABBV) and Amgen Inc. (AMGN) are both in the Healthcare sector, in the same Drug Manufacturers - General industry. ABBV trades on NYSE and AMGN on NASDAQ.

ABBV trades about 5.9 million shares a day on average, against 2.7 million for AMGN. AMGN has the higher beta (0.41 against 0.28 for ABBV), meaning it has historically moved more with the broad market. Over the trailing twelve months, ABBV paid $6.92 per share in dividends and AMGN paid $9.94 per share.

Figures as of October 25, 2026.

The chart Z-score-normalizes each closing series, computing (close − mean) ÷ standard deviation over the window, so both paths share one scale regardless of price level, and correlation is computed on daily returns. Figures update throughout the trading session. Nothing on this page is financial advice.